Despite impressive innovations in medicine, most advanced-stage cancers still carry a grim prognosis. Developing more ...

ZFTA–RELA is the cancer-promoting protein product of a gene fusion. Analyses of accessible sites in the DNA–protein complex chromatin in developing mice show that ZFTA–RELA binds to chromatin modules ...

A team at Huntsman Cancer Institute at the University of Utah (the U) has uncovered a previously unrecognized molecular ...

Like schools of fish and flocks of birds, our cells can also migrate collectively in coordination with their neighbors. This harmonious movement of cells occurs during embryonic development, wound ...

Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment. However, cancer cells have developed immune evasion strategies, leading to poor ...

The partnership will automate manufacturing of ProT-096, a personalized progenitor T-cell therapy for refractory leukemia and ...

Researchers at The University of Texas Medical Branch (UTMB) have identified how a key enzyme called ATR protects DNA from ...

India's TDB is supporting Helix Cell Therapeutics to develop an affordable, dual-targeting CAR-T therapy for multiple myeloma ...

The project is being led by Danielle Jex, a senior lecturer in immunology, and will investigate whether chemical signals ...

AI is transforming drug discovery, but accurately predicting patient responses remains challenging. Considering the ongoing need to connect drugs with the right patients and rising drug costs, ...

Scientists have made astonishing progress in treating one of the deadliest cancers.